April 3, 2017

Verseon Corporation (“Verseon” or the “Company”)

Announcement of 2017 Annual General Meeting

FREMONT, Calif.—Verseon Corporation (AIM:VSN), a technology-based pharmaceutical company, announces that its 2017 Annual General Meeting (“AGM”) will be held on April 25, 2017 at 2 p.m. local time at the Crowne Plaza San Jose - Silicon Valley, 777 Bellew Drive, Milpitas, CA, United States.

Copies of the following AGM documents will be available to view and download between April 3, 2017 and April 25, 2017 from the Company's website at http://www.verseon.com/investor-notices/agm2017:

  • Notice of 2017 Annual General Meeting of Shareholders
  • 2017 AGM Proxy Information Statement
  • Electronic Consent Form
-Ends-

For further information please contact

Verseon Corporation www.verseon.com
Arthur Shmurun / Amy Thai +1 (510) 225 9000
Cenkos Securities (NOMAD and Joint Broker)
Neil McDonald / Beth McKiernan +44 (0) 20 7397 8900
Cantor Fitzgerald Europe (Joint Broker)
Marc Milmo / Phil Davies / Callum Butterfield +44 (0) 20 7894 7000
Mirabaud Securities LLP (Joint Broker)
Peter Krens +44 (0) 20 7321 2508

For financial and business media enquiries, please contact

Buchanan Communications Ltd (PR Advisers)
Henry Harrison-Topham / Jamie Hooper +44 (0) 20 7466 5000

For trade and pharma media enquiries, please contact

Vane Percy & Roberts
Simon Vane Percy +44 (0) 1737 821 890

Our pledge

Verseon is committed to growth through innovation, building value for its shareholders while respecting its responsibilities as a good corporate citizen